Jump to main content
Jump to site search

Issue 2, 2018
Previous Article Next Article

A novel allosteric inhibitor that prevents IKKβ activation

Author affiliations

Abstract

I kappa B kinase β (IKKβ) is one of the primary targets to regulate canonical NF-κB activity. The misregulation of NF-κB is associated with various diseases, including chronic inflammation and cancers. Most of the known IKKβ inhibitors target its active form and suffer from poor selectivity. In the present study, we aim to design inhibitors that can bind to the IKKβ inactive form and block its activation. We identified a potential allosteric site between the kinase domain (KD) and ubiquitin-like domain (ULD) of human IKKβ and used it to virtually screen a chemical library for allosteric inhibitors. Among the 133 compounds tested, 16 inhibited NF-κB activity by over 50% at 50 μM in a reporter gene assay. Further quantitative measurements and cytotoxicity study gave one compound 124 (3,4-dichloro-2-ethoxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzenesulfonamide) which specifically targets the IKKβ inactive form. In cells, 124 inhibited IκBα phosphorylation and NF-κB transcriptional activity for the reporter gene with an IC50 of 35 μM by decreasing the phosphorylation level of Ser177/181 on IKKβ and blocking its activation upon TNFα stimulation. Molecular dynamics simulations demonstrated that 124 binds to the pocket between KD and ULD in the inactive conformation of IKKβ rather than the active conformation. As the first allosteric inhibitor that prevents IKKβ activation, 124 provides a good starting point for further inhibitor discovery and a probe for IKKβ enzyme cycle and regulatory mechanism study.

Graphical abstract: A novel allosteric inhibitor that prevents IKKβ activation

Back to tab navigation

Supplementary files

Publication details

The article was received on 25 Nov 2017, accepted on 05 Jan 2018 and first published on 09 Jan 2018


Article type: Research Article
DOI: 10.1039/C7MD00599G
Citation: Med. Chem. Commun., 2018,9, 239-243
  •   Request permissions

    A novel allosteric inhibitor that prevents IKKβ activation

    H. Liu, H. Liang, H. Meng, X. Deng, X. Zhang and L. Lai, Med. Chem. Commun., 2018, 9, 239
    DOI: 10.1039/C7MD00599G

Search articles by author

Spotlight

Advertisements